Dow Up 1.32% Nasdaq Up 1.60%

Merrimack Pharmaceuticals, Inc. (MACK)

-NasdaqGM
9.12 Oct 23, 4:00PM EDT
Prev Close:9.12
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:N/A
Beta:1.23
Earnings Date:Nov 5 - Nov 10 (Est.)
Day's Range:N/A - N/A
52wk Range:2.05 - 9.26
Volume:0
Avg Vol (3m):1,957,410
Market Cap:953.83M
P/E (ttm):N/A
EPS (ttm):-1.15
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
MACK 0.00%953.83M
IMMU350.11M
LRUSFN/A
THLD176.91M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):17.18
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.78
Quarterly EPS Est (Sep-14) :-0.12
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):-1.99

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Merrimack Pharmaceuticals, Inc., a biopharmaceutical company, is engaged in discovering, developing, and preparing to commercialize medicines paired with companion diagnostics for the treatment of cancer primarily in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback